Patents by Inventor Jitendra Belani

Jitendra Belani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents for drug-resistant influenza A
    Patent number: 11365174
    Abstract: An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: June 21, 2022
    Assignees: Thomas Jefferson University, Ramot At Tel-Aviv University LTD.
    Inventors: Nir Ben-Tal, Roger S. Armen, Laurence C. Eisenlohr, Jitendra Belani, Michael Miller, Inbar Fish, Ori Kalid
  • ANTIVIRAL AGENTS FOR DRUG-RESISTANT INFLUENZA A
    Publication number: 20200392076
    Abstract: An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through adminstration of the same.
    Type: Application
    Filed: April 27, 2020
    Publication date: December 17, 2020
    Inventors: Nir Ben-Tal, Roger S. Armen, Laurence C. Eisenlor, Jitendra Belani, Michael Miller, Inbar Fish, Ori Kalid
  • Antiviral agents for amantadine-resistant influenza A
    Patent number: 10676428
    Abstract: An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: June 9, 2020
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Nir Ben-Tal, Roger S. Armen, Laurence C. Eisenlohr, Jitendra Belani, Michael Miller, Inbar Fish, Ori Kalid
  • ANTIVIRAL AGENTS FOR AMANTADINE-RESISTANT INFLUENZA A
    Publication number: 20180370910
    Abstract: An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicants: Thomas Jefferson University, Ramot at Tel-Aviv University Ltd.
    Inventors: Nir Ben-Tal, Roger S. Armen, Laurence C. Eisenlohr, Jitendra Belani, Michael Miller, Inbar Fish, Ori Kalid